$10.60
$0.05 (+0.47%)
$10.50Day Range$10.75
Key Statistics
Market Cap
$750.25M
Shares Outstanding
70.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 23, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$10.67
Day High
$10.75
Day Low
$10.50
Volume
58.0K
VWAP
$10.65
Prev Close
$10.55
Transactions
--
Acc. Volume
--
About Pharming Group N.V. ADS, each representing 10 ordinary shares
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Identifiers
- CIK
- 0001828316
- Composite FIGI
- BBG00YN70VB3
- Share Class FIGI
- BBG00YN70W58
- Ticker Root
- PHAR
About Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) Stock
Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) closed the 2026-09-16 session at $10.60, up 0.47% versus the previous close (+0.05). The stock opened at $10.67 and traded between $10.50 and $10.75 during that session. Session trading volume was 58K shares. The volume-weighted average price (VWAP) is $10.65.
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Pharming Group N.V. ADS, each representing 10 ordinary shares has a market capitalization of $750.2 million. PHAR is listed on the XNAS exchange. The company employs approximately 409 people. The recorded listing date is 2020-12-23.
On this page you can find market PHAR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.